1	New	new	JJ	_	2	amod	_
2	technologies	technology	NNS	_	3	nsubj	3:A0=PAG
3	give	give	VBP	p2=VB|pb=give.01	0	root	_
4	vaccine	vaccine	NN	_	5	nn	_
5	developers	developer	NNS	_	3	iobj	3:A2=GOL
6	a	a	DT	p2=LS	7	det	_
7	boost	boost	NN	_	3	dobj	3:A1=PPT
8	in	in	IN	_	7	prep	_
9	early	early	JJ	_	10	amod	_
10	development	development	NN	_	8	pobj	_
11	,	,	,	_	3	punct	_
12	but	but	CC	_	3	cc	_
13	large	large	JJ	_	15	hmod	_
14	-	-	HYPH	_	15	hyph	_
15	scale	scale	NN	_	16	nn	_
16	testing	testing	NN	_	20	nsubjpass	20:A1=PPT
17	and	and	CC	_	16	cc	_
18	production	production	NN	_	16	conj	_
19	are	be	VBP	_	20	auxpass	_
20	bogged	bog	VBN	p2=VBD|pb=bog.01	3	conj	_
21	down	down	RP	p2=IN	20	prt	20:C-V
22	by	by	IN	_	20	agent	20:A0=PAG
23	high	high	JJ	_	24	amod	_
24	costs	cost	NNS	_	22	pobj	_
25	and	and	CC	_	24	cc	_
26	lengthy	lengthy	JJ	_	27	amod	_
27	trials	trial	NNS	_	24	conj	_
28	.	.	.	_	20	punct	_

1	Deadly	deadly	JJ	p2=RB	3	amod	_
2	new	new	JJ	_	3	amod	_
3	viruses	virus	NNS	_	5	nsubj	5:A1=PPT
4	can	can	MD	_	5	aux	5:AM-MOD
5	spread	spread	VB	p2=VBD|pb=spread.02	0	root	_
6	far	far	RB	_	8	advmod	_
7	more	more	RBR	_	8	advmod	_
8	quickly	quickly	RB	_	5	advmod	5:AM-MNR
9	than	than	IN	_	11	mark	_
10	drugmakers	drugmaker	NNS	_	11	nsubj	11:A1=PPT
11	operate	operate	VBP	pb=operate.01	8	advcl	_
12	.	.	.	_	5	punct	_

1	Emerging	emerge	VBG	p2=JJ|pb=emerge.01	2	amod	_
2	infection	infection	NN	_	0	root	1:A0=PPT
3	:	:	:	_	2	punct	_
4	MERS	mers	NNS	p2=NNP	5	nn	_
5	virus	virus	NN	p2=VBP	6	nn	_
6	particles	particle	NNS	_	8	nsubjpass	8:A1=PPT
7	are	be	VBP	_	8	auxpass	_
8	shown	show	VBN	pb=show.01	2	ccomp	_
9	in	in	IN	p2=RP	8	prep	8:AM-LOC
10	yellow	yellow	JJ	p2=NN	9	pobj	_
11	in	in	IN	_	8	prep	8:AM-LOC
12	this	this	DT	_	16	det	_
13	colorized	colorized	JJ	p2=VBN	16	amod	_
14	electron	electron	NN	_	15	nn	_
15	microscope	microscope	NN	_	16	nn	_
16	image	image	NN	_	11	pobj	_
17	.	.	.	_	2	punct	_

1	Middle	middle	NNP	p2=JJ	2	nn	_
2	East	east	NNP	p2=JJ	4	nn	_
3	respiratory	respiratory	JJ	_	4	amod	_
4	syndrome	syndrome	NN	_	10	nsubj	10:A1=PPT
5	,	,	,	_	4	punct	_
6	or	or	CC	_	4	cc	_
7	MERS	mers	NNP	p2=NNS	4	conj	_
8	,	,	,	_	7	punct	_
9	is	be	VBZ	_	10	aux	_
10	spreading	spread	VBG	pb=spread.03	0	root	_
11	across	across	IN	_	10	prep	10:AM-DIR
12	the	the	DT	_	13	det	_
13	globe	globe	NN	_	11	pobj	_
14	,	,	,	_	10	punct	_
15	and	and	CC	_	10	cc	_
16	while	while	IN	_	21	mark	_
17	a	a	DT	_	18	det	_
18	vaccine	vaccine	NN	_	21	nsubjpass	21:A1=PRD
19	could	could	MD	_	21	aux	21:AM-MOD
20	be	be	VB	_	21	auxpass	_
21	developed	develop	VBN	pb=develop.02	24	advcl	24:AM-ADV
22	,	,	,	_	24	punct	_
23	there	there	EX	_	24	expl	_
24	's	be	VBZ	pb=be.02	10	conj	_
25	little	little	JJ	_	27	amod	_
26	commercial	commercial	JJ	_	27	amod	_
27	incentive	incentive	NN	_	24	attr	24:A1=PPT
28	to	to	TO	_	29	aux	_
29	make	make	VB	pb=make.01	27	infmod	_
30	one	#crd#	CD	p2=NN	29	dobj	29:A1=PRD
31	.	.	.	_	24	punct	_

1	The	the	DT	_	3	det	_
2	deadly	deadly	JJ	_	3	amod	_
3	virus	virus	NN	_	6	nsubjpass	6:A1=PPT
4	was	be	VBD	_	6	auxpass	_
5	first	#ord#	RB	_	6	advmod	6:AM-TMP
6	identified	identify	VBN	pb=identify.01	0	root	_
7	in	in	IN	_	6	prep	6:AM-LOC
8	Saudi	saudi	NNP	_	9	nn	_
9	Arabia	arabia	NNP	_	7	pobj	_
10	in	in	IN	_	6	prep	6:AM-TMP
11	2012	0	CD	_	10	pobj	_
12	.	.	.	_	6	punct	_

1	Since	since	IN	_	7	prep	7:AM-TMP
2	then	then	RB	_	1	pcomp	_
3	,	,	,	_	7	punct	_
4	infected	infected	JJ	_	5	amod	_
5	people	people	NNS	_	7	nsubj	7:A1=PPT
6	have	have	VBP	_	7	aux	_
7	turned	turn	VBN	pb=turn.15	0	root	_
8	up	up	RP	_	7	prt	7:C-V
9	in	in	IN	_	7	prep	7:AM-LOC
10	Europe	europe	NNP	_	9	pobj	_
11	,	,	,	_	10	punct	_
12	Africa	africa	NNP	_	10	conj	_
13	,	,	,	_	12	punct	_
14	and	and	CC	_	12	cc	_
15	Asia	asia	NNP	_	12	conj	_
16	.	.	.	_	7	punct	_

1	The	the	DT	_	3	det	_
2	first	#ord#	JJ	_	3	amod	_
3	cases	case	NNS	_	4	nsubj	4:A1=PPT;12:A1=PPT
4	arrived	arrive	VBD	p2=VBN|pb=arrive.01	0	root	_
5	in	in	IN	_	4	prep	4:A4=LOC
6	the	the	DT	_	8	det	_
7	United	united	NNP	_	8	nn	_
8	States	states	NNP	_	5	pobj	_
9	this	this	DT	_	10	det	_
10	month	month	NN	_	4	npadvmod	4:AM-TMP
11	,	,	,	_	4	punct	_
12	beginning	begin	VBG	pb=begin.01	4	advcl	4:AM-PRD
13	with	with	IN	_	12	prep	12:A2=MNR
14	two	#crd#	CD	_	16	num	_
15	infected	infected	JJ	p2=VBN	16	amod	_
16	travelers	traveler	NNS	_	13	pobj	17:A1=PPT
17	returning	return	VBG	pb=return.01	16	partmod	_
18	from	from	IN	_	17	prep	17:A3=DIR
19	Saudi	saudi	NNP	_	20	nn	_
20	Arabia	arabia	NNP	_	18	pobj	_
21	.	.	.	_	4	punct	_

1	On	on	IN	_	5	prep	5:AM-TMP
2	Saturday	saturday	NNP	_	1	pobj	_
3	,	,	,	_	5	punct	_
4	authorities	authority	NNS	_	5	nsubj	5:A0=PAG
5	reported	report	VBD	pb=report.01	0	root	_
6	the	the	DT	_	13	det	_
7	first	#ord#	JJ	_	13	amod	_
8	person	person	NN	_	12	hmod	_
9	-	-	HYPH	_	12	hyph	_
10	to	to	IN	_	12	hmod	_
11	-	-	HYPH	_	12	hyph	_
12	person	person	NN	_	13	nn	_
13	transmission	transmission	NN	_	5	dobj	5:A1
14	within	within	IN	_	13	prep	_
15	the	the	DT	_	16	det	_
16	U.S.	u.s.	NNP	_	14	pobj	_
17	,	,	,	_	5	punct	_
18	most	most	RBS	_	19	advmod	_
19	likely	likely	RB	p2=JJ	20	advmod	_
20	from	from	IN	_	5	prep	_
21	a	a	DT	_	27	det	_
22	face	face	NN	_	26	hmod	_
23	-	-	HYPH	_	26	hyph	_
24	to	to	IN	_	26	hmod	_
25	-	-	HYPH	_	26	hyph	_
26	face	face	NN	_	27	nn	_
27	conversation	conversation	NN	_	20	pobj	_
28	.	.	.	_	5	punct	_

1	While	while	IN	_	10	mark	_
2	DNA	dna	NNP	p2=NN	3	nn	_
3	sequencing	sequencing	NN	p2=VBG	10	nsubj	10:A0=PAG
4	and	and	CC	_	3	cc	_
5	synthesis	synthesis	NN	_	3	conj	_
6	and	and	CC	_	5	cc	_
7	other	other	JJ	_	9	amod	_
8	biomedical	biomedical	JJ	_	9	amod	_
9	technologies	technology	NNS	_	5	conj	_
10	offer	offer	VBP	pb=offer.01	33	advcl	33:AM-ADV
11	ways	way	NNS	_	10	dobj	10:A1=PPT;14:AM-MNR
12	to	to	TO	_	14	aux	_
13	quickly	quickly	RB	_	14	advmod	14:AM-MNR
14	devise	devise	VB	pb=devise.01	11	infmod	_
15	experimental	experimental	JJ	_	16	amod	_
16	treatments	treatment	NNS	_	14	dobj	14:A1=PPT
17	for	for	IN	_	16	prep	_
18	sudden	sudden	JJ	_	20	amod	_
19	disease	disease	NN	_	20	nn	_
20	outbreaks	outbreak	NNS	p2=VBZ	17	pobj	_
21	like	like	IN	p2=UH	20	prep	_
22	MERS	mers	NNP	p2=NNS	21	pobj	_
23	,	,	,	_	22	punct	_
24	the	the	DT	_	26	det	_
25	greater	great	JJR	_	26	amod	_
26	challenge	challenge	NN	_	22	appos	_
27	is	be	VBZ	_	33	auxpass	_
28	the	the	DT	_	30	det	_
29	formidable	formidable	JJ	_	30	amod	_
30	cost	cost	NN	_	33	nsubjpass	35:A0=PAG;33:A1=PPT
31	and	and	CC	_	30	cc	_
32	time	time	NN	_	30	conj	_
33	needed	need	VBN	p2=VBD|pb=need.01	0	root	_
34	to	to	TO	_	35	aux	_
35	test	test	VB	pb=test.01	33	xcomp	33:C-A1
36	a	a	DT	_	38	det	_
37	new	new	JJ	_	38	amod	_
38	vaccine	vaccine	NN	_	35	dobj	35:A1=LOC
39	.	.	.	_	33	punct	_

1	The	the	DT	_	2	det	_
2	need	need	NN	_	8	nsubj	_
3	for	for	IN	_	2	prep	_
4	a	a	DT	_	6	det	_
5	MERS	mers	NNP	p2=NNS	6	nn	_
6	vaccine	vaccine	NN	_	3	pobj	_
7	certainly	certainly	RB	_	8	advmod	8:AM-ADV
8	seems	seem	VBZ	pb=seem.01	0	root	_
9	urgent	urgent	JJ	_	8	oprd	8:A1=PPT
10	.	.	.	_	8	punct	_

1	While	while	IN	_	15	mark	_
2	the	the	DT	_	4	det	_
3	U.S.	u.s.	NNP	_	4	nn	_
4	resident	resident	NN	_	15	nsubjpass	7:A1;11:A1=GOL;15:A1=PPT;18:A1=PPT
5	most	most	RBS	_	6	advmod	_
6	recently	recently	RB	_	7	advmod	7:AM-TMP
7	reported	report	VBN	p2=VBD|pb=report.01	4	partmod	_
8	to	to	TO	_	11	aux	_
9	have	have	VB	_	11	aux	_
10	been	be	VBN	_	11	auxpass	_
11	infected	infect	VBN	pb=infect.01	7	xcomp	7:A2=GOL
12	by	by	IN	_	11	agent	11:A0=PAG
13	MERS	mers	NNP	p2=NNS	12	pobj	_
14	is	be	VBZ	_	15	auxpass	_
15	said	say	VBN	pb=say.01	26	advcl	26:AM-ADV
16	to	to	TO	_	18	aux	_
17	have	have	VB	_	18	aux	_
18	recovered	recover	VBN	pb=recover.01	15	xcomp	15:C-A1
19	with	with	IN	_	18	prep	18:A2=DIR
20	no	no	DT	_	22	det	_
21	medical	medical	JJ	_	22	amod	_
22	intervention	intervention	NN	_	19	pobj	_
23	,	,	,	_	26	punct	_
24	he	he	PRP	_	26	nsubjpass	26:A1=PPT;30:A1=GOL
25	is	be	VBZ	_	26	auxpass	_
26	believed	believe	VBN	pb=believe.01	0	root	_
27	to	to	TO	_	30	aux	_
28	have	have	VB	_	30	aux	_
29	been	be	VBN	_	30	auxpass	_
30	infected	infect	VBN	pb=infect.01	26	xcomp	26:C-A1
31	from	from	IN	_	30	prep	30:A2=PPT
32	a	a	DT	_	39	det	_
33	face	face	NN	_	37	hmod	_
34	-	-	HYPH	_	37	hyph	_
35	to	to	IN	_	37	hmod	_
36	-	-	HYPH	_	37	hyph	_
37	face	face	NN	_	39	nn	_
38	business	business	NN	_	39	nn	_
39	meeting	meeting	NN	_	31	pobj	41:A1=PPT
40	that	that	WDT	_	41	nsubj	41:R-A1
41	lasted	last	VBD	pb=last.01	39	rcmod	_
42	just	just	RB	_	43	advmod	_
43	40	0	CD	_	44	num	_
44	minutes	minute	NNS	_	41	npadvmod	41:A2=VSP
45	.	.	.	_	26	punct	_

1	Others	other	NNS	_	4	nsubj	4:A0=PAG
2	have	have	VBP	_	4	aux	_
3	not	not	RB	_	4	neg	4:AM-NEG
4	had	have	VBN	p2=VBD|pb=have.03	0	root	_
5	such	such	JJ	_	7	amod	_
6	fortunate	fortunate	JJ	_	7	amod	_
7	outcomes	outcome	NNS	_	4	dobj	4:A1=PPT
8	.	.	.	_	4	punct	_

1	Approximately	approximately	RB	_	4	advmod	_
2	one	#crd#	CD	_	4	hmod	_
3	-	-	HYPH	_	4	hyph	_
4	third	#ord#	NN	_	11	nsubj	11:A1=PPT
5	of	of	IN	_	4	prep	_
6	those	those	DT	_	5	pobj	7:A1=PPT
7	diagnosed	diagnose	VBN	pb=diagnose.01	6	partmod	_
8	with	with	IN	_	7	prep	7:A2=PRD
9	MERS	mers	NNS	p2=NNP	8	pobj	_
10	have	have	VBP	_	11	aux	_
11	died	die	VBN	pb=die.01	0	root	_
12	,	,	,	_	11	punct	_
13	according	accord	VBG	_	11	prep	11:AM-ADV
14	to	to	IN	_	13	prep	_
15	the	the	DT	_	16	det	_
16	Centers	center	NNPS	_	14	pobj	_
17	for	for	IN	_	16	prep	_
18	Disease	disease	NNP	_	19	nn	_
19	Control	control	NNP	_	17	pobj	_
20	and	and	CC	_	19	cc	_
21	Prevention	prevention	NNP	_	19	conj	_
22	.	.	.	_	11	punct	_

1	The	the	DT	_	2	det	_
2	virus	virus	NN	_	4	nsubjpass	4:A1=PPT
3	is	be	VBZ	_	4	auxpass	_
4	transmitted	transmit	VBN	pb=transmit.01	0	root	_
5	from	from	IN	_	4	prep	_
6	person	person	NN	_	5	pobj	_
7	to	to	IN	_	4	prep	_
8	person	person	NN	_	10	hmod	_
9	-	-	HYPH	p2=,	10	hyph	_
10	including	include	VBG	p2=NN	7	pobj	_
11	from	from	IN	_	4	prep	4:A2=GOL
12	patient	patient	JJ	p2=NN	11	pobj	_
13	to	to	IN	_	12	prep	_
14	health	health	NN	_	16	hmod	_
15	-	-	HYPH	_	16	hyph	_
16	care	care	NN	_	17	nn	_
17	worker	worker	NN	_	21	nsubj	21:A2=GOL
18	-	-	HYPH	p2=,	17	hyph	_
19	and	and	CC	_	17	cc	_
20	symptoms	symptom	NNS	_	17	conj	_
21	include	include	VBP	pb=include.01	4	conj	_
22	fever	fever	NN	_	21	dobj	21:A1=PPT
23	,	,	,	_	22	punct	_
24	cough	cough	NN	_	22	conj	_
25	,	,	,	_	24	punct	_
26	and	and	CC	_	24	cc	_
27	shortness	shortness	NN	_	24	conj	_
28	of	of	IN	_	27	prep	_
29	breath	breath	NN	_	28	pobj	_
30	.	.	.	_	4	punct	_

1	Unfortunately	unfortunately	RB	_	5	advmod	5:AM-ADV
2	,	,	,	_	5	punct	_
3	drug	drug	NN	_	4	nn	_
4	companies	company	NNS	_	5	nsubj	5:A0
5	see	see	VBP	pb=see.01	0	root	_
6	less	less	JJR	_	7	amod	_
7	urgency	urgency	NN	_	5	dobj	5:A1
8	.	.	.	_	5	punct	_

1	And	and	CC	_	13	cc	13:AM-DIS
2	while	while	IN	_	5	mark	_
3	researchers	researcher	NNS	_	5	nsubj	_
4	can	can	MD	_	5	aux	5:AM-MOD
5	develop	develop	VB	pb=develop.01	13	advcl	13:AM-ADV
6	experimental	experimental	JJ	_	7	amod	_
7	vaccines	vaccine	NNS	_	5	dobj	5:A1=LOC
8	quickly	quickly	RB	_	9	advmod	_
9	enough	enough	RB	p2=JJ	5	advmod	5:AM-MNR
10	,	,	,	_	13	punct	_
11	it	it	PRP	_	13	nsubj	13:A0
12	typically	typically	RB	_	13	advmod	13:AM-TMP
13	takes	take	VBZ	pb=take.10	0	root	_
14	a	a	DT	_	17	det	_
15	big	big	JJ	_	17	amod	_
16	pharmaceutical	pharmaceutical	JJ	p2=NN	17	amod	_
17	company	company	NN	_	13	dobj	21:A0=PAG;13:A1
18	to	to	TO	_	19	aux	_
19	test	test	VB	pb=test.01	17	infmod	_
20	and	and	CC	_	19	cc	_
21	manufacture	manufacture	VB	pb=manufacture.01	19	conj	_
22	it	it	PRP	_	21	dobj	21:A1=PRD
23	.	.	.	_	13	punct	_

1	There	there	EX	p2=RB	3	expl	_
2	just	just	RB	_	3	advmod	3:AM-ADV
3	are	be	VBP	pb=be.02	0	root	_
4	n't	not	RB	_	3	neg	3:AM-NEG
5	enough	enough	JJ	_	6	amod	_
6	cases	case	NNS	_	3	attr	11:A0;3:A1=PPT
7	of	of	IN	_	6	prep	_
8	MERS	mers	NNS	p2=NNP	7	pobj	_
9	yet	yet	RB	_	3	advmod	3:AM-TMP
10	to	to	TO	_	11	aux	_
11	establish	establish	VB	pb=establish.01	3	advcl	_
12	a	a	DT	_	14	det	_
13	guaranteed	guarantee	VBN	p2=JJ|pb=guarantee.01	14	amod	_
14	market	market	NN	_	11	dobj	11:A1=PPT;13:A1=PPT
15	for	for	IN	_	11	prep	11:AM-PRP
16	a	a	DT	_	17	det	_
17	vaccine	vaccine	NN	_	15	pobj	_
18	.	.	.	_	3	punct	_

1	"	"	``	_	33	punct	_
2	In	in	IN	_	11	prep	11:AM-LOC
3	the	the	DT	_	4	det	_
4	U.S.	u.s.	NNP	_	2	pobj	_
5	,	,	,	_	11	punct	_
6	generally	generally	RB	_	7	advmod	7:AM-ADV
7	speaking	speak	VBG	pb=speak.01	11	advcl	11:AM-ADV
8	,	,	,	_	11	punct	_
9	it	it	PRP	_	11	nsubj	11:A0
10	will	will	MD	_	11	aux	11:AM-MOD
11	take	take	VB	pb=take.01	33	ccomp	33:A1=PPT
12	a	a	DT	_	13	det	_
13	decade	decade	NN	_	11	dobj	11:A1=PPT
14	or	or	CC	_	15	cc	_
15	more	more	JJR	p2=RBR	13	num	_
16	and	and	CC	_	11	cc	_
17	just	just	RB	_	18	advmod	_
18	shy	shy	JJ	p2=RB	11	conj	_
19	of	of	IN	_	18	prep	_
20	a	a	DT	_	21	quantmod	_
21	billion	#crd#	CD	_	22	num	_
22	dollars	dollar	NNS	_	19	pobj	_
23	to	to	TO	_	24	aux	_
24	get	get	VB	pb=get.01	18	advcl	_
25	a	a	DT	_	26	det	_
26	vaccine	vaccine	NN	_	24	dobj	24:A1=PPT;27:A1=PPT
27	licensed	license	VBN	p2=XX|pb=license.01	26	partmod	_
28	through	through	IN	_	27	prep	27:AM-MNR
29	the	the	DT	_	30	det	_
30	FDA	fda	NNP	_	28	pobj	_
31	,	,	,	_	33	punct	_
32	"	"	''	_	33	punct	_
33	says	say	VBZ	pb=say.01	0	root	_
34	Gregory	gregory	NNP	_	35	nn	_
35	Poland	poland	NNP	_	33	nsubj	33:A0;38:A0=PPT
36	,	,	,	_	35	punct	_
37	who	who	WP	_	38	nsubj	38:R-A0
38	heads	head	VBZ	pb=head.01	35	rcmod	_
39	the	the	DT	_	42	det	_
40	Vaccine	vaccine	NNP	_	42	nn	_
41	Research	research	NNP	_	42	nn	_
42	Group	group	NNP	_	38	dobj	38:A1=PPT
43	at	at	IN	_	38	prep	_
44	the	the	DT	_	46	det	_
45	Mayo	mayo	NNP	_	46	nn	_
46	Clinic	clinic	NNP	_	43	pobj	_
47	.	.	.	_	33	punct	_

1	The	the	DT	_	2	det	_
2	reason	reason	NN	_	3	nsubj	3:A1=PPT
3	is	be	VBZ	pb=be.01	0	root	_
4	human	human	JJ	_	5	amod	_
5	testing	testing	NN	_	3	attr	8:A1=PPT;3:A2=PRD
6	,	,	,	_	5	punct	_
7	which	which	WDT	_	8	nsubj	8:R-A1
8	is	be	VBZ	pb=be.01	5	rcmod	_
9	costly	costly	JJ	_	8	acomp	8:A2=PRD
10	and	and	CC	_	8	cc	_
11	must	must	MD	_	12	aux	12:AM-MOD
12	prove	prove	VB	pb=prove.01	8	conj	_
13	not	not	RB	_	18	preconj	_
14	only	only	RB	_	13	advmod	_
15	that	that	IN	p2=DT	18	complm	_
16	a	a	DT	_	17	det	_
17	vaccine	vaccine	NN	_	18	nsubj	18:A0=PAG
18	works	work	VBZ	p2=NNS|pb=work.01	12	advcl	_
19	but	but	CC	_	18	cc	_
20	also	also	RB	_	19	advmod	_
21	that	that	IN	_	23	mark	_
22	it	it	PRP	_	23	nsubj	23:A0=PAG
23	produces	produce	VBZ	pb=produce.01	18	conj	_
24	no	no	DT	p2=UH	27	det	_
25	harmful	harmful	JJ	_	27	amod	_
26	side	side	NN	p2=JJ	27	nn	_
27	effects	effect	NNS	_	23	dobj	23:A1
28	.	.	.	_	3	punct	_

1	Furthermore	furthermore	RB	_	13	advmod	13:AM-DIS
2	,	,	,	_	13	punct	_
3	because	because	IN	_	6	mark	_
4	viruses	virus	NNS	_	6	nsubj	6:A1=PPT
5	can	can	MD	_	6	aux	6:AM-MOD
6	mutate	mutate	VB	p2=RB|pb=mutate.01	13	advcl	13:AM-CAU
7	quickly	quickly	RB	_	6	advmod	6:AM-MNR
8	,	,	,	_	13	punct	_
9	the	the	DT	_	11	det	_
10	financial	financial	JJ	_	11	amod	_
11	risks	risk	NNS	_	13	nsubj	13:A1=PPT
12	can	can	MD	_	13	aux	13:AM-MOD
13	be	be	VB	pb=be.01	16	ccomp	16:A1=PPT
14	huge	huge	JJ	_	13	acomp	13:A2=PRD
15	,	,	,	_	16	punct	_
16	says	say	VBZ	pb=say.01	0	root	_
17	William	william	NNP	_	18	nn	_
18	Carter	carter	NNP	_	16	nsubj	16:A0
19	,	,	,	_	18	punct	_
20	CEO	ceo	NN	p2=NNP	18	appos	_
21	of	of	IN	_	20	prep	_
22	Hemispherx	hemispherx	NNP	_	23	nn	_
23	Biopharma	biopharma	NNP	_	21	pobj	_
24	,	,	,	_	23	punct	_
25	a	a	DT	_	29	det	_
26	Philadelphia	philadelphia	NNP	_	28	hmod	_
27	-	-	HYPH	_	28	hyph	_
28	based	base	VBN	_	29	amod	_
29	company	company	NN	_	23	appos	30:A2=PPT
30	developing	develop	VBG	pb=develop.01	29	partmod	_
31	treatments	treatment	NNS	_	30	dobj	30:A1=LOC
32	for	for	IN	_	31	prep	_
33	viral	viral	JJ	_	34	amod	_
34	infections	infection	NNS	_	32	pobj	_
35	including	include	VBG	_	34	prep	_
36	MERS	mers	NNP	p2=NNS	35	pobj	_
37	.	.	.	_	16	punct	_

1	"	"	``	_	17	punct	_
2	The	the	DT	_	4	det	_
3	apparent	apparent	JJ	_	4	amod	_
4	utility	utility	NN	_	9	nsubj	9:A1=PPT
5	of	of	IN	_	4	prep	_
6	the	the	DT	_	7	det	_
7	vaccine	vaccine	NN	_	5	pobj	_
8	can	can	MD	_	9	aux	9:AM-MOD
9	vaporize	vaporize	VB	pb=vaporize.01	17	ccomp	17:A1=PPT
10	before	before	IN	_	9	prep	9:AM-LOC
11	your	your	PRP$	_	13	poss	_
12	very	very	JJ	p2=RB	13	amod	_
13	eyes	eye	NNS	_	10	pobj	_
14	,	,	,	_	17	punct	_
15	"	"	''	_	17	punct	_
16	he	he	PRP	_	17	nsubj	17:A0
17	says	say	VBZ	pb=say.01	0	root	_
18	.	.	.	_	17	punct	_

1	New	new	JJ	p2=NNP	2	amod	_
2	technologies	technology	NNS	_	4	nsubj	4:A0=PAG
3	do	do	VBP	_	4	aux	_
4	allow	allow	VB	p2=JJ|pb=allow.01	0	root	_
5	experimental	experimental	JJ	_	6	amod	_
6	vaccines	vaccine	NNS	_	9	nsubjpass	9:A1=PRD
7	to	to	TO	_	9	aux	_
8	be	be	VB	_	9	auxpass	_
9	developed	develop	VBN	pb=develop.02	4	ccomp	4:A1=PPT
10	quickly	quickly	RB	_	9	advmod	9:AM-MNR
11	,	,	,	_	4	punct	_
12	although	although	IN	_	16	mark	_
13	those	those	DT	_	14	det	_
14	vaccines	vaccine	NNS	_	16	nsubj	16:A0=PAG
15	still	still	RB	_	16	advmod	16:AM-TMP
16	require	require	VBP	pb=require.01	4	advcl	4:AM-ADV
17	testing	testing	NN	p2=VBG	16	dobj	16:A1=PPT
18	.	.	.	_	4	punct	_

1	In	in	IN	_	18	prep	18:AM-TMP
2	March	march	NNP	_	1	pobj	_
3	2013	0	CD	_	2	num	_
4	,	,	,	_	18	punct	_
5	the	the	DT	_	7	det	_
6	first	#ord#	JJ	_	7	amod	_
7	cases	case	NNS	_	18	nsubjpass	18:A1=PPT
8	of	of	IN	_	7	prep	_
9	people	people	NNS	_	8	pobj	11:A1=GOL
10	being	be	VBG	_	11	auxpass	_
11	infected	infect	VBN	pb=infect.01	9	partmod	_
12	by	by	IN	_	11	agent	11:A0=PAG
13	the	the	DT	_	16	det	_
14	avian	avian	JJ	_	15	amod	_
15	flu	flu	NN	_	16	nn	_
16	H7N9	h7n9	NNP	p2=NN	12	pobj	_
17	were	be	VBD	_	18	auxpass	_
18	identified	identify	VBN	pb=identify.01	0	root	_
19	in	in	IN	_	18	prep	18:AM-LOC
20	China	china	NNP	_	19	pobj	_
21	.	.	.	_	18	punct	_

1	Ten	#crd#	CD	_	2	num	_
2	days	day	NNS	_	3	npadvmod	_
3	after	after	IN	_	7	mark	_
4	the	the	DT	_	6	det	_
5	Chinese	chinese	JJ	_	6	amod	_
6	government	government	NN	_	7	nsubj	7:A0=PAG
7	announced	announce	VBD	pb=announce.01	37	advcl	37:AM-TMP;45:AM-TMP
8	the	the	DT	_	9	det	_
9	outbreak	outbreak	NN	_	7	dobj	7:A1=PPT
10	,	,	,	_	37	punct	_
11	the	the	DT	_	13	det	_
12	biopharmaceutical	biopharmaceutical	JJ	_	13	amod	_
13	company	company	NN	_	37	nsubj	19:A0=PAG;37:A0=PAG;45:A0=PAG
14	Novavax	novavax	NNP	_	13	appos	_
15	-	-	,	p2=HYPH	13	punct	_
16	which	which	WDT	_	19	nsubj	19:R-A0
17	was	be	VBD	_	19	aux	_
18	already	already	RB	_	19	advmod	19:AM-TMP
19	working	work	VBG	pb=work.01	13	rcmod	_
20	under	under	IN	_	19	prep	19:AM-LOC
21	a	a	DT	_	22	det	_
22	contract	contract	NN	_	20	pobj	_
23	with	with	IN	_	22	prep	_
24	the	the	DT	_	26	det	_
25	U.S.	u.s.	NNP	_	26	nn	_
26	government	government	NN	_	23	pobj	_
27	to	to	TO	_	28	aux	_
28	develop	develop	VB	pb=develop.02	22	infmod	_
29	a	a	DT	_	30	det	_
30	vaccine	vaccine	NN	_	28	dobj	28:A1=PRD
31	against	against	IN	_	30	prep	_
32	the	the	DT	_	35	det	_
33	H5N1	h5n1	NNP	p2=JJ	34	nn	_
34	bird	bird	NN	_	35	nn	_
35	flu	flu	NN	_	37	nsubj	_
36	-	-	HYPH	p2=,	37	hyph	_
37	received	receive	VBD	p2=VBN|pb=receive.01	0	root	_
38	the	the	DT	_	40	det	_
39	genetic	genetic	JJ	_	40	amod	_
40	sequence	sequence	NN	_	37	dobj	37:A1=PPT
41	of	of	IN	_	40	prep	_
42	the	the	DT	_	43	det	_
43	virus	virus	NN	_	41	pobj	_
44	and	and	CC	_	37	cc	_
45	began	begin	VBD	pb=begin.01	37	conj	_
46	developing	develop	VBG	pb=develop.01	45	xcomp	45:A1=PPT
47	a	a	DT	_	48	det	_
48	vaccine	vaccine	NN	_	46	dobj	46:A1=LOC
49	.	.	.	_	37	punct	_

1	Just	just	RB	_	2	advmod	_
2	six	#crd#	CD	_	3	num	_
3	months	month	NNS	_	4	npadvmod	_
4	after	after	IN	p2=RB	9	mark	_
5	the	the	DT	_	7	det	_
6	H7N9	h7n9	NNP	p2=CD	7	nn	_
7	virus	virus	NN	_	9	nsubjpass	9:A1
8	was	be	VBD	_	9	auxpass	_
9	sequenced	sequence	VBN	p2=JJ|pb=sequence.01	16	advcl	16:AM-TMP
10	,	,	,	_	16	punct	_
11	Novavax	novavax	NNP	_	14	poss	_
12	's	's	POS	_	11	possessive	_
13	experimental	experimental	JJ	_	14	amod	_
14	vaccine	vaccine	NN	_	16	nsubjpass	16:A1=LOC
15	was	be	VBD	_	16	auxpass	_
16	tested	test	VBN	pb=test.01	0	root	_
17	in	in	IN	_	16	prep	16:AM-LOC
18	humans	human	NNS	_	17	pobj	_
19	with	with	IN	_	18	prep	_
20	positive	positive	JJ	_	21	amod	_
21	results	result	NNS	_	19	pobj	_
22	.	.	.	_	16	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	3	nsubj	5:A0=PAG;3:A1=PPT
3	continues	continue	VBZ	pb=continue.01	0	root	_
4	to	to	TO	_	5	aux	_
5	develop	develop	VB	pb=develop.02	3	xcomp	3:C-A1
6	the	the	DT	_	7	det	_
7	product	product	NN	_	5	dobj	5:A1=PRD
8	with	with	IN	_	7	prep	_
9	U.S.	u.s.	NNP	_	11	nn	_
10	government	government	NN	_	11	nn	_
11	support	support	NN	_	8	pobj	_
12	,	,	,	_	3	punct	_
13	although	although	IN	_	17	mark	_
14	it	it	PRP	_	17	nsubj	17:A1=PPT
15	must	must	MD	_	17	aux	17:AM-MOD
16	still	still	RB	_	17	advmod	17:AM-TMP
17	go	go	VB	pb=go.06	3	advcl	_
18	through	through	IN	_	17	prep	17:A2=DIR
19	lengthy	lengthy	JJ	_	20	amod	_
20	testing	testing	NN	_	18	pobj	_
21	.	.	.	_	3	punct	_

1	The	the	DT	_	2	det	_
2	approach	approach	NN	_	6	nsubj	6:A0=CAU;3:A1=PPT
3	used	use	VBN	pb=use.01	2	partmod	_
4	by	by	IN	_	3	agent	3:A0=PAG
5	Novavax	novavax	NNP	_	4	pobj	_
6	shows	show	VBZ	p2=NNS|pb=show.01	0	root	_
7	how	how	WRB	_	8	advmod	_
8	rapidly	rapidly	RB	_	12	advmod	12:R-AM-MNR
9	a	a	DT	_	10	det	_
10	vaccine	vaccine	NN	_	12	nsubj	12:A0=PPT
11	can	can	MD	_	12	aux	12:AM-MOD
12	emerge	emerge	VB	pb=emerge.01	6	ccomp	6:A1=PPT
13	from	from	IN	_	12	prep	12:A1
14	the	the	DT	_	16	det	_
15	lab	lab	NN	_	16	nn	_
16	bench	bench	NN	_	13	pobj	_
17	.	.	.	_	6	punct	_

1	Instead	instead	RB	_	2	advmod	_
2	of	of	IN	_	29	prep	29:AM-ADV
3	copying	copy	VBG	pb=copy.01	2	pcomp	_
4	viral	viral	JJ	_	5	amod	_
5	DNA	dna	NN	p2=NNP	3	dobj	3:A1=PPT
6	using	use	VBG	pb=use.01	3	conj	_
7	bacteria	bacteria	NNS	_	6	dobj	10:A0;11:A0;6:A1=PPT
8	,	,	,	_	7	punct	_
9	which	which	WDT	_	10	nsubj	10:R-A0;11:R-A0
10	requires	require	VBZ	pb=require.01	7	rcmod	_
11	acquiring	acquire	VBG	pb=acquire.01	10	xcomp	10:A1=PPT
12	a	a	DT	_	13	det	_
13	copy	copy	NN	_	11	dobj	11:A1=PPT
14	of	of	IN	_	13	prep	_
15	the	the	DT	_	16	det	_
16	virus	virus	NN	_	18	poss	_
17	's	's	POS	_	16	possessive	_
18	genome	genome	NN	p2=NNS	14	pobj	_
19	,	,	,	_	13	punct	_
20	a	a	DT	_	25	det	_
21	potentially	potentially	RB	_	24	advmod	_
22	time	time	NN	_	24	hmod	_
23	-	-	HYPH	_	24	hyph	_
24	consuming	consume	VBG	_	25	amod	_
25	process	process	NN	_	13	conj	_
26	,	,	,	_	29	punct	_
27	the	the	DT	_	28	det	_
28	company	company	NN	_	29	nsubj	29:A0=PAG
29	had	have	VBD	pb=have.03	0	root	_
30	the	the	DT	_	31	det	_
31	DNA	dna	NNP	p2=NN	32	nsubj	32:A1=PRD
32	synthesized	synthesize	VBN	p2=VBD|pb=synthesize.01	29	ccomp	29:A1=PPT
33	chemically	chemically	RB	_	32	advmod	32:AM-MNR
34	,	,	,	_	36	punct	_
35	then	then	RB	_	36	advmod	36:AM-TMP
36	used	use	VBN	p2=VBD|pb=use.01	32	dep	_
37	cultured	cultured	JJ	p2=VBD	39	amod	_
38	insect	insect	JJ	p2=NN	39	amod	_
39	cells	cell	NNS	_	36	dobj	36:A1=PPT
40	to	to	TO	_	41	aux	_
41	produce	produce	VB	pb=produce.01	36	xcomp	36:A2=PRP
42	bits	bit	NNS	_	41	dobj	41:A1
43	of	of	IN	_	42	prep	_
44	protein	protein	NN	_	43	pobj	_
45	from	from	IN	_	42	prep	_
46	that	that	DT	p2=IN	47	det	_
47	DNA	dna	NN	p2=NNP	45	pobj	_
48	.	.	.	_	29	punct	_

1	The	the	DT	_	3	det	_
2	protein	protein	NN	_	3	nn	_
3	bits	bit	NNS	_	5	nsubjpass	5:A1=PPT
4	were	be	VBD	_	5	auxpass	_
5	combined	combine	VBN	pb=combine.01	0	root	_
6	into	into	IN	_	5	prep	5:A2=PPT
7	a	a	DT	_	11	det	_
8	virus	virus	NN	_	10	hmod	_
9	-	-	HYPH	_	10	hyph	_
10	sized	sized	JJ	_	11	amod	_
11	nanoparticle	nanoparticle	NN	p2=NNS	6	pobj	14:A1=PPT
12	that	that	WDT	_	14	nsubjpass	14:R-A1
13	was	be	VBD	_	14	auxpass	_
14	used	use	VBN	pb=use.01	11	rcmod	_
15	as	as	IN	_	14	prep	14:A2=PRP
16	the	the	DT	_	17	det	_
17	vaccine	vaccine	NN	_	15	pobj	_
18	(	(	-LRB-	_	19	punct	_
19	see	see	VB	p2=UH|pb=see.01	17	parataxis	_
20	"	"	``	p2=''	19	punct	_
21	Delivering	deliver	VBG	pb=deliver.01	19	xcomp	19:A1
22	a	a	DT	_	25	det	_
23	Virus	virus	NNP	p2=NNPS	25	nn	_
24	Imposter	imposter	NNP	_	25	nn	_
25	Quicker	quicker	NNP	_	21	dobj	21:A1=PPT
26	"	"	''	_	25	punct	_
27	)	)	-RRB-	_	19	punct	_
28	.	.	.	_	5	punct	_

1	And	and	CC	_	31	cc	31:AM-DIS
2	so	so	RB	_	31	advmod	31:AM-DIS
3	,	,	,	_	31	punct	_
4	while	while	IN	_	14	mark	_
5	researchers	researcher	NNS	_	14	nsubj	14:A0=PAG
6	at	at	IN	_	5	prep	_
7	the	the	DT	_	8	det	_
8	University	university	NNP	_	11	nn	_
9	of	of	IN	_	8	prep	_
10	Maryland	maryland	NNP	_	9	pobj	_
11	School	school	NNP	_	6	pobj	_
12	of	of	IN	_	11	prep	_
13	Medicine	medicine	NNP	_	12	pobj	_
14	reported	report	VBD	pb=report.01	31	advcl	31:AM-ADV
15	last	last	JJ	_	16	amod	_
16	month	month	NN	_	14	npadvmod	14:AM-TMP
17	that	that	IN	p2=WDT	22	complm	_
18	Novavax	novavax	NNP	_	20	poss	_
19	's	's	POS	_	18	possessive	_
20	vaccine	vaccine	NN	_	22	nsubj	22:A0=PAG
21	can	can	MD	_	22	aux	22:AM-MOD
22	generate	generate	VB	pb=generate.01	14	ccomp	14:A1
23	anti-MERS	anti-mers	NNS	p2=JJ	24	nn	_
24	antibodies	antibody	NNS	p2=VBZ	22	dobj	22:A1=PPT
25	in	in	IN	_	22	prep	_
26	mice	mouse	NNS	p2=NN	25	pobj	_
27	,	,	,	_	31	punct	_
28	they	they	PRP	_	31	nsubj	31:A0=CAU
29	could	could	MD	_	31	aux	31:AM-MOD
30	not	not	RB	_	31	neg	31:AM-NEG
31	show	show	VB	pb=show.01	0	root	_
32	whether	whether	IN	_	37	complm	_
33	that	that	DT	p2=IN	35	det	_
34	immune	immune	JJ	_	35	amod	_
35	response	response	NN	_	37	nsubj	37:A0=PAG
36	actually	actually	RB	_	37	advmod	37:AM-ADV
37	protected	protect	VBD	pb=protect.01	31	ccomp	31:A1=PPT
38	the	the	DT	_	39	det	_
39	animals	animal	NNS	_	37	dobj	37:A1=PPT
40	against	against	IN	_	37	prep	37:A2=PPT
41	any	any	DT	_	42	det	_
42	disease	disease	NN	_	40	pobj	_
43	.	.	.	_	31	punct	_

1	The	the	DT	_	3	det	_
2	next	next	JJ	_	3	amod	_
3	step	step	NN	_	6	nsubj	6:A0=PAG
4	will	will	MD	_	6	aux	6:AM-MOD
5	be	be	VB	_	6	aux	_
6	finding	find	VBG	pb=find.01	0	root	_
7	a	a	DT	_	9	det	_
8	suitable	suitable	JJ	_	9	amod	_
9	animal	animal	NN	_	6	dobj	6:A1=PPT
10	for	for	IN	_	9	prep	_
11	testing	testing	NN	_	10	pobj	_
12	,	,	,	_	11	punct	_
13	perhaps	perhaps	RB	_	16	advmod	_
14	a	a	DT	_	16	det	_
15	non-human	non-human	JJ	p2=NN	16	amod	_
16	primate	primate	NN	_	11	conj	_
17	or	or	CC	_	16	cc	_
18	a	a	DT	_	19	det	_
19	mouse	mouse	NN	_	16	conj	24:A1=PPT;26:A1=PPT
20	that	that	WDT	_	24	nsubjpass	24:R-A1;26:R-A1
21	has	have	VBZ	_	24	aux	_
22	been	be	VBN	_	24	auxpass	_
23	genetically	genetically	RB	_	24	advmod	24:AM-MNR
24	altered	alter	VBN	pb=alter.01	19	rcmod	_
25	to	to	TO	_	26	aux	_
26	be	be	VB	pb=be.01	24	advcl	24:AM-PRP
27	susceptible	susceptible	JJ	_	26	acomp	26:A2=PRD
28	.	.	.	_	6	punct	_

1	You	you	PRP	_	2	nsubj	2:A1=PPT
2	're	be	VBP	pb=be.01	0	root	_
3	automatically	automatically	RB	_	2	advmod	2:AM-ADV
4	an	an	DT	_	5	det	_
5	Insider	insider	NNP	p2=NN	2	attr	2:A2=PRD
6	.	.	.	_	2	punct	_

1	It	it	PRP	_	2	nsubj	_
2	's	be	VBZ	pb=be.01	0	root	_
3	easy	easy	JJ	_	2	acomp	2:A2=PRD
4	to	to	TO	_	5	aux	_
5	activate	activate	VB	pb=activate.01	2	xcomp	2:A1=PPT
6	or	or	CC	_	5	cc	_
7	upgrade	upgrade	VB	pb=upgrade.02	5	conj	_
8	your	your	PRP$	_	9	poss	_
9	account	account	NN	_	7	dobj	7:A1=PPT
10	.	.	.	_	2	punct	_

1	It	it	PRP	_	2	nsubj	2:A1=PPT
2	's	be	VBZ	pb=be.01	0	root	_
3	the	the	DT	_	5	det	_
4	new	new	JJ	_	5	amod	_
5	way	way	NN	_	2	attr	2:A2=PRD;7:AM-MNR
6	to	to	TO	_	7	aux	_
7	subscribe	subscribe	VB	pb=subscribe.02	5	infmod	_
8	.	.	.	_	2	punct	_

1	Get	get	VB	p2=VBP|pb=get.01	0	root	_
2	even	even	RB	_	3	advmod	_
3	more	more	JJR	p2=RBR	1	dobj	1:A1=PPT
4	of	of	IN	_	3	prep	_
5	the	the	DT	_	7	det	_
6	tech	tech	NN	p2=JJ	7	nn	_
7	news	news	NN	_	4	pobj	_
8	,	,	,	_	7	punct	_
9	research	research	NN	_	7	conj	_
10	,	,	,	_	9	punct	_
11	and	and	CC	_	9	cc	_
12	discoveries	discovery	NNS	p2=VBZ	9	conj	_
13	you	you	PRP	_	14	nsubj	14:A0=PAG
14	crave	crave	VBP	pb=crave.01	7	rcmod	_
15	.	.	.	_	1	punct	_

1	Find	find	VB	pb=find.03	0	root	_
2	out	out	RP	_	1	prt	1:C-V
3	why	why	WRB	_	8	advmod	8:R-AM-CAU
4	MIT	mit	NNP	_	6	nn	_
5	Technology	technology	NNP	p2=NN	6	nn	_
6	Review	review	NNP	_	7	nn	_
7	Insider	insider	NNP	_	8	nsubj	8:A1=PPT
8	is	be	VBZ	pb=be.01	1	ccomp	1:A1=PPT
9	for	for	IN	_	8	prep	8:A2=PRD
10	you	you	PRP	_	9	pobj	_
11	and	and	CC	_	1	cc	_
12	explore	explore	VB	pb=explore.01	1	conj	_
13	your	your	PRP$	_	14	poss	_
14	options	option	NNS	_	12	dobj	12:A1
15	.	.	.	_	1	punct	_

